Oncorus, Inc.
ONCRDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671818
Oncorus, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Dec 30, 2022; 32 institutions reported holding it in 13F filings for Q1 2023, worth $3.78M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Oncorus, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −7 vs. Q3 2022
- Shares held
- 15.6M
- −918.6K (−5.6%) vs. Q3 2022
- Total value
- $3.95M
- −$10.1M (−71.9%) vs. Q3 2022
- New holders
- 1
- 8 more added
- Sold out
- 8
- 15 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ONCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 1 | $3 |
| Q2 2023 | 4 | $212.1K |
| Q1 2023 | 32 | $3.78M |
| Q4 2022 | 33 | $3.95M |
| Q3 2022 | 40 | $14.1M |
| Q2 2022 | 45 | $21.4M |
| Q1 2022 | 56 | $34.5M |
| Q4 2021 | 56 | $107.1M |
| Q3 2021 | 48 | $186.2M |
| Q2 2021 | 50 | $282.6M |
| Q1 2021 | 57 | $278.2M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Oncorus, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 353 | $0 | 0.00% | −953−73.0% | Reduced |
| Royal Bank of Canada | 228 | $0 | 0.00% | +3+1.3% | Added |
| Your Advocates Ltd., LLP | 100 | $25 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 133 | $34 | 0.00% | +4+3.1% | Added |
| Citigroup Inc | 506 | $128 | 0.00% | +15+3.1% | Added |
| Tower Research Capital LLC (TRC) | 8,602 | $2.00K | 0.00% | −2,555−22.9% | Reduced |
| Morgan Stanley | 8,394 | $2.13K | 0.00% | −6,995−45.5% | Reduced |
| Barclays PLC | 9,495 | $2.40K | 0.00% | −866−8.4% | Reduced |
| Jane Street Group, LLC | 11,972 | $3.03K | 0.00% | +11,972 | New |
| Ergoteles LLC | 14,707 | $3.73K | 0.00% | −71,428−82.9% | Reduced |
| Goldman Sachs Group Inc | 17,189 | $4.35K | 0.00% | −7,222−29.6% | Reduced |
| HSBC Holdings PLC | 26,452 | $7.14K | 0.00% | +32+0.1% | Added |
| Northern Trust Corp | 28,960 | $7.34K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 44,788 | $11.3K | 0.00% | +32,026+250.9% | Added |
| Two Sigma Investments, LP | 62,792 | $15.9K | 0.00% | −18,700−22.9% | Reduced |
| Bank of New York Mellon Corp | 66,498 | $16.8K | 0.00% | −497−0.7% | Reduced |
| Bridgeway Capital Management, LLC | 67,300 | $17.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 70,135 | $17.8K | 0.00% | 00.0% | Unchanged |
| SG Americas Securities, LLC | 72,692 | $18.0K | 0.00% | +36,355+100.0% | Added |
| Two Sigma Advisers, LP | 99,200 | $25.1K | 0.00% | −8,900−8.2% | Reduced |
| We Are One Seven, LLC | 116,354 | $29.5K | 0.00% | −350.0% | Reduced |
| Geode Capital Management, LLC | 137,927 | $34.0K | 0.00% | −299−0.2% | Reduced |
| BlackRock Inc. | 139,672 | $35.4K | 0.00% | −132,692−48.7% | Reduced |
| Millennium Management LLC | 276,358 | $70.0K | 0.00% | −91,668−24.9% | Reduced |
| Renaissance Technologies LLC | 286,936 | $73.0K | 0.00% | +77,403+36.9% | Added |
| Vanguard Group Inc | 495,913 | $125.6K | 0.00% | −401−0.1% | Reduced |
| Sphera Funds Management Ltd. | 540,258 | $136.8K | 0.04% | 00.0% | Unchanged |
| Fosun International Ltd | 962,323 | $243.8K | 0.02% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,924,422 | $487.5K | 0.00% | +9,828+0.5% | Added |
| CHI Advisors LLC | 2,367,436 | $599.7K | 0.16% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 2,377,031 | $601.4K | 0.16% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,536,186 | $642.4K | 0.01% | −612,791−19.5% | Reduced |
| MPM Asset Management LLC | 2,849,464 | $720.9K | 0.30% | 00.0% | Unchanged |
| Letko, Brosseau & Associates Inc | 0 | $0 | 0.00% | −59,150−100.0% | Sold out |
| Sawtooth Solutions, LLC | 0 | $0 | 0.00% | −36,748−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −15,874−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −13,642−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,604−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −905−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −243−100.0% | Sold out |